Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea; Department of Radiology, Namwon Medical Center, Jeollabuk-do, Republic of Korea.
Eur Urol. 2018 Jan;73(1):81-91. doi: 10.1016/j.eururo.2017.03.042. Epub 2017 Apr 12.
Magnetic resonance imaging (MRI) has been tested for detecting bone metastasis and has shown promising results. Yet, consensus has not been reached regarding whether it can replace the role of bone scintigraphy in this clinical setting or not.
To review the diagnostic performance of contemporary (≥1.5 T) MRI for the detection of bone metastasis in patients with prostate cancer.
MEDLINE and EMBASE were searched up to January 22, 2017. We included studies that used MRI using ≥1.5-T scanners for the detection of bone metastasis in patients with prostate cancer, using histopathology or best value comparator as the reference standard. Two independent reviewers assessed the methodological quality using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Per-patient sensitivity and specificity of included studies were calculated, and pooled and plotted in a hierarchical summary receiver operating characteristic plot. Meta-regression and sensitivity analyses were performed.
Ten studies (1031 patients) were included. Pooled sensitivity was 0.96 (95% confidence interval [CI] 0.87-0.99) with a specificity of 0.98 (95% CI 0.93-0.99). At meta-regression analysis, only the number of imaging planes (≥2 vs 1) was a significant factor affecting heterogeneity (p<0.01). Sensitivity analyses showed that specificity estimates were comparable and consistently high across all subgroups, but sensitivity estimates demonstrated some differences. Studies using two or more planes (n=4) had the highest sensitivity (0.99 [95% CI 0.98-1.00]).
Contemporary MRI shows excellent sensitivity and specificity for detection of bone metastasis in patients with prostate cancer. Using two or more imaging planes may further improve sensitivity. However, caution is needed in applying our results due to the heterogeneity among the included studies.
We reviewed studies using contemporary magnetic resonance imaging (MRI) for the detection of bone metastasis in prostate cancer patients. MRI shows excellent diagnostic performance in finding patients with bone metastasis.
磁共振成像(MRI)已被用于检测骨转移,并显示出良好的效果。然而,关于其是否可以替代核素骨扫描在这种临床环境下的作用,尚未达成共识。
回顾使用现代(≥1.5T)MRI 检测前列腺癌患者骨转移的诊断性能。
检索了 MEDLINE 和 EMBASE,检索日期截至 2017 年 1 月 22 日。我们纳入了使用≥1.5T 扫描仪检测前列腺癌患者骨转移的 MRI 研究,以组织病理学或最佳价值比较器作为参考标准。两位独立的审稿人使用诊断准确性研究的质量评估-2 工具评估了方法学质量。计算了纳入研究的每位患者的敏感性和特异性,并在分层汇总受试者工作特征图中进行了汇总和绘制。进行了荟萃回归和敏感性分析。
纳入了 10 项研究(1031 例患者)。汇总敏感性为 0.96(95%置信区间 [CI] 0.87-0.99),特异性为 0.98(95% CI 0.93-0.99)。在荟萃回归分析中,只有成像平面数(≥2 个与 1 个)是影响异质性的显著因素(p<0.01)。敏感性分析表明,特异性估计在所有亚组中均相似且始终较高,但敏感性估计存在一些差异。使用两个或更多平面(n=4)的研究具有最高的敏感性(0.99 [95% CI 0.98-1.00])。
现代 MRI 对检测前列腺癌患者的骨转移具有出色的敏感性和特异性。使用两个或更多成像平面可能进一步提高敏感性。但是,由于纳入研究之间存在异质性,在应用我们的结果时需要谨慎。
我们回顾了使用现代磁共振成像(MRI)检测前列腺癌患者骨转移的研究。MRI 在发现有骨转移的患者方面具有出色的诊断性能。